Catalyst Wire Dossier Catalyst Wire Dossier

Novartis Meningococcal C Conjugate Vaccine

Meningococcal C conjugate vaccine · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Novartis Meningococcal C Conjugate Vaccine, covering 2014-03-26 to 2014-03-26. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers [Phase 2]

See pricing